<DOC>
	<DOCNO>NCT02576054</DOCNO>
	<brief_summary>This study V501 [ quadrivalent Human Papillomavirus ( HPV ) ( Type 6 , 11 , 16 18 ) L1 Virus-Like Particle ( VLP ) vaccine ] healthy Japanese boy . This study consist two period . Period I study evaluate immunogenicity tolerability V501 Month 7 . Period II study evaluate long-term immunogenicity safety Month 7 Month 30 . Two analysis plan . The first analysis conduct subject complete Month 7 visit discontinue time . The second analysis conduct end study . The primary hypothesis test study seroconversion rate vaccine HPV type &gt; 90 % 4 week postdose 3 .</brief_summary>
	<brief_title>Safety Tolerability Study V501 Japanese Boys ( V501-200 )</brief_title>
	<detailed_description />
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Papilloma</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<criteria>Healthy Japanese male Have legal representative provide write informed consent trial participant 's behalf Have legal representative able read , understand , complete vaccine report card Has yet coitarche plan become sexually active Day 1 Month 7 study Other inclusion criterion discuss investigator screen Currently enrol clinical study investigational agent History know prior vaccination HPV vaccine plan receive one outside study History severe allergic reaction require medical intervention Allergic vaccine component , include aluminum , yeast , BENZONASEâ„¢ Received immune globulin bloodderived product past 6 month plan receive Month 7 study History splenectomy , currently immunocompromised , diagnosed immunodeficiency , Human Immunodeficiency Virus ( HIV ) infection , lymphoma , leukemia , systemic lupus erythematosus , rheumatoid arthritis , juvenile rheumatoid arthritis , inflammatory bowel disease , autoimmune condition Received immunosuppressive therapy past year , exclude inhale , nasal , topical corticosteroid Known thrombocytopenia coagulation disorder would contraindicate intramuscular injection Ongoing alcohol drug abuse within past 12 month History genital wart positive test HPV</criteria>
	<gender>Male</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>